PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 140 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2014. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $192,000 | -1.0% | 20,909 | +4.9% | 0.00% | – |
| Q1 2021 | $194,000 | -3.0% | 19,929 | +2.4% | 0.00% | – |
| Q4 2020 | $200,000 | +4.7% | 19,458 | +2.6% | 0.00% | – |
| Q3 2020 | $191,000 | -1.5% | 18,956 | 0.0% | 0.00% | – |
| Q2 2020 | $194,000 | +11.5% | 18,956 | -8.1% | 0.00% | – |
| Q1 2020 | $174,000 | +0.6% | 20,626 | +4.2% | 0.00% | – |
| Q4 2019 | $173,000 | -22.4% | 19,796 | -0.9% | 0.00% | – |
| Q3 2019 | $223,000 | -12.2% | 19,977 | 0.0% | 0.00% | – |
| Q2 2019 | $254,000 | -66.2% | 19,977 | +3.3% | 0.00% | -100.0% |
| Q1 2019 | $751,000 | -14.6% | 19,340 | +0.9% | 0.00% | 0.0% |
| Q3 2018 | $879,000 | -31.9% | 19,169 | -12.1% | 0.00% | 0.0% |
| Q2 2018 | $1,290,000 | -13.5% | 21,815 | -0.5% | 0.00% | -50.0% |
| Q1 2018 | $1,491,000 | -31.6% | 21,917 | -0.6% | 0.00% | 0.0% |
| Q4 2017 | $2,180,000 | -17.2% | 22,049 | +0.3% | 0.00% | -33.3% |
| Q3 2017 | $2,633,000 | +35.0% | 21,983 | -1.4% | 0.00% | +50.0% |
| Q2 2017 | $1,950,000 | +139.9% | 22,299 | +2.0% | 0.00% | +100.0% |
| Q1 2017 | $813,000 | +37.8% | 21,862 | +13.7% | 0.00% | 0.0% |
| Q4 2016 | $590,000 | -48.4% | 19,222 | +12.8% | 0.00% | -50.0% |
| Q3 2016 | $1,143,000 | +124.6% | 17,038 | -0.2% | 0.00% | +100.0% |
| Q2 2016 | $509,000 | +1936.0% | 17,080 | +1781.1% | 0.00% | – |
| Q1 2016 | $25,000 | -64.8% | 908 | 0.0% | 0.00% | – |
| Q4 2015 | $71,000 | -12.3% | 908 | -15.7% | 0.00% | – |
| Q3 2015 | $81,000 | -37.2% | 1,077 | -2.8% | 0.00% | – |
| Q2 2015 | $129,000 | -98.4% | 1,108 | -96.8% | 0.00% | -100.0% |
| Q1 2015 | $8,083,000 | +15.9% | 34,233 | -7.1% | 0.01% | 0.0% |
| Q4 2014 | $6,976,000 | -15.4% | 36,858 | +6.7% | 0.01% | -16.7% |
| Q3 2014 | $8,242,000 | +285.1% | 34,550 | +6.6% | 0.01% | +300.0% |
| Q2 2014 | $2,140,000 | +22.0% | 32,418 | +92.4% | 0.00% | 0.0% |
| Q1 2014 | $1,754,000 | -1.0% | 16,845 | -1.6% | 0.00% | 0.0% |
| Q4 2013 | $1,772,000 | +98.2% | 17,119 | +2.8% | 0.00% | +200.0% |
| Q3 2013 | $894,000 | +16.9% | 16,655 | -3.4% | 0.00% | 0.0% |
| Q2 2013 | $765,000 | – | 17,236 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
| Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
| Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
| Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
| Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
| RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
| PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
| Eversept Partners, LP | 58,251 | $491,638 | 0.12% |